Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
CAS:
Ref. 3D-FL146829
Informação sobre produto
Nome:Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
Sinónimos:
- 1,1,1,3,3,3-Hexamethyldisilazane lithium saltLithium bis(trimethylsilyl)amide
Marca:Biosynth
Descrição:Lithium hexamethyl disilazide solution is an inhibitor drug that blocks the synthesis of pyrimidine compounds. It has been shown to be effective in congestive heart failure, hyperproliferative diseases such as pancreatitis and dyslipoproteinemia, coronary heart diseases, and HIV infection. Lithium hexamethyl disilazide solution binds to the cb2 receptor on the surface of activated T cells, which inhibits their ability to cause inflammation or autoimmune disease. This drug also has nitrogen atoms that are reactive and asymmetric, making it a good candidate for an inhibitor drug.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:167.33 g/mol
Fórmula:C6H18LiNSi2
Pureza:Min. 95%